China NT Pharma Group Co., Ltd. Financial Overview
China NT Pharma Group Co., Ltd.'s market cap is currently HK$566.37M. The company's EPS TTM is HK$-0.032; its P/E ratio is -3.69; China NT Pharma Group Co., Ltd. is scheduled to report earnings on August 8, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
